New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could ...

A stepwise HIV vaccine strategy has induced broadly neutralizing antibodies in primates, hinting that a truly protective HIV ...

But politics could derail the one thing to unlock it.

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. speaks as President Donald Trump listens at an event to promote his ...

Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully generated high levels of broadly ne ...

Until recently, human vaccine development has typically taken 10 to 15 years. But during the COVID-19 pandemic, vaccines like the Vaxzevria vaccine produced by the University of Oxford and AstraZeneca ...

Vaxcyte's VAX-31 is in a Phase 3 pivotal OPUS-1 noninferiority trial and is expecting topline data in 4Q 2026. Learn more ...

The World Health Organization announced Monday a new project to accelerate the development in poorer countries of vaccines for human bird flu infections using cutting-edge messenger RNA technology.

An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...

The University of Maryland School of Medicine Center for Vaccine Development and Global Health (CVD), has announced the ...